Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-09, Stock:PFE, The news for the past five days is as follows:
2019-01-02: NEWS1: The best-performing sector last year could be the top bet for 2019, technician says.NEWS2: The 3 Best Stocks in the Dow Jones in 2018.NEWS3: The 3 Best Stocks in the Dow Jones in 2018.NEWS4: Your first trade for Wednesday, January 2.NEWS5: Health Care Sector Update for 01/02/2019: PRQR, PTLA, NTEC, JNJ, PFE, ABT, MRK, AMGN.NEWS6: Health Care Sector Update for 01/02/2019: PRQR, PTLA, NTEC, JNJ, PFE, ABT, MRK, AMGN.NEWS7: The 3 Best Stocks in the Dow Jones in 2018.NEWS8: Pfizer Could Be a Healthy Option in This Volatile Market.NEWS9: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for January 03, 2019.NEWS10: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for January 03, 2019.NEWS11: SNY Named Top 10 SAFE International Dividend Stock.NEWS12: SNY Named Top 10 SAFE International Dividend Stock.NEWS13: This 2019 Market Optimism Is Misplaced: Market Recon.NEWS14: Dow Jones Futures Signal Sell-Off To Open 2019 Stock Market; Trump Says 'Let's Make A Deal'.NEWS15: Dow Jones Futures Dive On China Data; Will 'Make A Deal' Trump Fuel 2019 Market Rally?.NEWS16: Dow Jones Futures Fall On China Data; Will 'Make A Deal' Trump Fuel 2019 Market Rally?.NEWS17: Dow Jones Futures: Will 'Let's Make A Deal' Trump Fuel 2019 Stock Market Rally?.NEWS18: Drugmakers Raise Prices on Hundreds of Medicines.NEWS19: Dow Jones Futures: 'Let's Make A Deal' Trump Fuels 2019 Stock Market Rally.NEWS20: [$$] Drugmakers Raise Prices on Hundreds of Medicines.
2019-01-03: NEWS1: Why Johnson & Johnson Stock is Clearly Set to Rise Again.NEWS2: Why Johnson & Johnson Stock is Clearly Set to Rise Again.NEWS3: 3 Biopharma Stocks to Buy for Their Robust Dividend Yields.NEWS4: 3 Biopharma Stocks to Buy for Their Robust Dividend Yields.NEWS5: Why Johnson & Johnson Stock is Clearly Set to Rise Again.NEWS6: 3 Biopharma Stocks to Buy for Their Robust Dividend Yields.NEWS7: Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019?.NEWS8: Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019?.NEWS9: Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019?.NEWS10: Pfizer Initiates Phase 2b/3 Clinical Trial for PF-06651600, an Oral JAK3 Inhibitor, for the Treatment of Patients with Moderate to Severe Alopecia Areata.
2019-01-04: NEWS1: Bristol To Become Top 5 Pharma — And Other Fallout From Celgene Takeover.NEWS2: Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate.NEWS3: Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate.NEWS4: Nektar, ImaginAb Enter Into Immuno-Oncology Collaboration.NEWS5: Nektar, ImaginAb Enter Into Immuno-Oncology Collaboration.NEWS6: Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate.NEWS7: Health Care Sector Update for 01/04/2019: FLKS, NVAX, ESPR, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 01/04/2019: FLKS, NVAX, ESPR, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Pfizer Begins Pivotal Study on Alopecia Areata Candidate.NEWS10: Pfizer Begins Pivotal Study on Alopecia Areata Candidate.NEWS11: Pfizer Rises 3%.NEWS12: Pfizer Begins Pivotal Study on Alopecia Areata Candidate.NEWS13: Today's Research Reports on Trending Tickers: Pfizer and Bristol-Myers Squibb.
2019-01-07: NEWS1: Aerie's Rhopressa Succeeds in Study on Japanese Patients.NEWS2: Aerie's Rhopressa Succeeds in Study on Japanese Patients.NEWS3: Top Dow Stocks for 2018.NEWS4: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS5: Biogen Inks Two Deals to Make Drugs for Neurological Diseases.NEWS6: Biogen Inks Two Deals to Make Drugs for Neurological Diseases.NEWS7: Aerie's Rhopressa Succeeds in Study on Japanese Patients.NEWS8: Why Exact Sciences Soared Today.NEWS9: Biogen Inks Two Deals to Make Drugs for Neurological Diseases.NEWS10: Pfizer or Eli Lilly: Whose Revenue Is Growing More Quickly?.NEWS11: GlaxoSmithKline CEO Emma Walmsley gets &apos;radical&apos; about reshaping portfolio.NEWS12: GlaxoSmithKline CEO Emma Walmsley gets 'radical' about reshaping portfolio.NEWS13: Analysts’ Recommendations for Eli Lilly in January.NEWS14: Company News For Jan 7, 2019.NEWS15: Company News For Jan 7, 2019.NEWS16: IVV, GOOG, GOOGL, PFE: ETF Inflow Alert.NEWS17: IVV, GOOG, GOOGL, PFE: ETF Inflow Alert.NEWS18: GSK CEO: Pfizer venture creates value for both our consum....NEWS19: Analysts’ Recommendations for Pfizer in January.NEWS20: Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?.NEWS21: Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?.NEWS22: As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock.NEWS23: Company News For Jan 7, 2019.NEWS24: Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?.NEWS25: J.P. Morgan Healthcare Conference kicks off Monday with focus on Trump, Amazon.NEWS26: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie.NEWS27: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie.NEWS28: Pfizer To Present At The J.P. Morgan Conference; Webcast At 11:30 AM ET.NEWS29: Pfizer To Present At The J.P. Morgan Conference; Webcast At 11:30 AM ET.NEWS30: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie.NEWS31: Pfizer To Use CytoReason's Machine Learning Model For Drug Discovery.NEWS32: Pfizer To Use CytoReason's Machine Learning Model For Drug Discovery.
2019-01-08: NEWS1: Pfizer or Eli Lilly: Which Company Is More Cost Efficient?.NEWS2: Dogs of the Dow Win in 2018: Will ETFs See Success in 2019?.NEWS3: Dogs of the Dow Win in 2018: Will ETFs See Success in 2019?.NEWS4: Health Care Sector Update for 01/08/2019: AXSM, AKRX, NVS, JNJ, PFE, MRK, ABT, AMGN.NEWS5: Health Care Sector Update for 01/08/2019: AXSM, AKRX, NVS, JNJ, PFE, MRK, ABT, AMGN.NEWS6: Pfizer or Eli Lilly: Which Company Has Better Margins?.NEWS7: 3 Companies You Don't Realize You Rely On Every Day.NEWS8: 3 Companies You Don't Realize You Rely On Every Day.NEWS9: Dogs of the Dow Win in 2018: Will ETFs See Success in 2019?.NEWS10: Pfizer or Eli Lilly: Whose Earnings Are Seeing Better Growth?.NEWS11: 3 Companies You Don&apos;t Realize You Rely On Every Day.NEWS12: 3 Things Pfizer's New CEO Just Said That Investors Will be Glad to Hear.NEWS13: 3 Things Pfizer's New CEO Just Said That Investors Will be Glad to Hear.NEWS14: 3 Things Pfizer&apos;s New CEO Just Said That Investors Will be Glad to Hear.NEWS15: Gilead, Pfizer Execs Suggest Even More Pharma M&A Is on Way.NEWS16: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS17: Pfizer (PFE) Gains But Lags Market: What You Should Know.

Answer: Decrease